Skip to content
OpenCapital
Get started

Haemonetics HAE Hospital — R&D

Other segment segments

Plasma
$4.94M+15.4%
Blood Center
$1.03M-26.3%

Similar metrics at other companies

STERIS logo
STEHealthcare — R&D
$25.3M+6.8%
OSI Systems logo
OSISHealthcare Division — Research And Development Expense
$4.63M+7.7%
Abbott logo
ABTDiagnostic Products — R&D
$155M+2.6%
West Pharmaceutical Services logo
WSTProprietary Products — R&D
$15.8M-3.1%
Abbott logo
ABTMedical Devices — R&D
$444M+10.7%
Baxter International logo
BAXHealthcare Systems & Technologies — Research and development expenses
$49M+8.9%

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's hospital — r&d.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's hospital — R&D?
Haemonetics (HAE) reported hospital — R&D of $8.46M in Q1 2026.
How has Haemonetics's hospital — R&D changed year-over-year?
Haemonetics's hospital — R&D decreased by 6.2% year-over-year, from $9.01M to $8.46M.
What is the long-term trend for Haemonetics's hospital — R&D?
Over 3 years (2023 to 2026), Haemonetics's hospital — R&D has grown at a 13.9% compound annual growth rate (CAGR), from $23.1M to $34.09M.
What does hospital — R&D mean?
Captures the investment allocated to the discovery, design, and clinical validation of new medical products and technologies within the hospital segment. This spending is critical for maintaining long-term competitive advantage and driving future revenue growth through innovation.